Background Medication‐related osteonecrosis of the jaw (MRONJ) is a severe adverse
reaction experienced by some individuals to certain medicines commonly used in the …

Background Antiresorptive agents such as bisphosphonates and denosumab, as well as
angiogenesis inhibitors, may induce medication-related osteonecrosis of the jaw (MRONJ) …

Platelet-rich plasma (PRP) has been utilized for many years as a regenerative agent
capable of inducing vascularization of various tissues using blood-derived growth factors …

Medication-related osteonecrosis of the jaw (MRONJ) is a serious side effect of bone-
modifying agents and inhibits angiogenesis agents. Although the pathogenesis of MRONJ is …

Tooth extraction has been avoided since it has been considered a major risk factor for
medication-related osteonecrosis of the jaw (MRONJ). However, MRONJ may also develop …

The aim of this systematic review was to answer the question: Is the application of
autologous platelet concentrates (APCs) effective in the prevention and treatment of …

Medication‐related osteonecrosis of the jaw (MRONJ) is an infectious side effect associated
with bisphosphonates and monoclonal antibodies (denosumab, immune modulators, and …

There is currently widespread interest within the biomaterial field to locally deliver
biomolecules for bone and cartilage regeneration. Substantial work to date has focused on …

Platelet concentrates, mostly represented by platelet-rich plasma and platelet-rich fibrin,
have gained significant interest in various medical and oral disciplines because of their …

Medication-related osteonecrosis of the jaw (MRONJ) is one of the most interesting diseases
in the field of maxillofacial surgery. In addition to bisphosphonates, the use of antiresorptive …